The relatıonshıp Between Upper Extremity Exercise Test and Exercise Capacity ın patıents wıth Idiopathic Pulmonary Fibrosis

NCT07119099 | Completed

• 1 other identifier: 14/2025
• Study Type: observational
• Target: 21
• Locations: 1 country
• Sites: 2

Brief Summary

The primary aim of our study was to investigate the relationship between 6PBRT outcome measures and 6MWT, 1MSTST and UULEX outcome measures. The secondary aim is to investigate the predictors of 6PBRT test.

Conditions

Idiopathic Pulmonary Fibrosis (IPF)

Keywords

6-minute pegboard and ring test; upper extremity; exercise capacity; idiopathic pulmonary fibrosis

Outcome Measures

Primary Outcomes (4)

• 1 Minute Sit to Stand Test (1MSTST)

  The 1-Minute Sit-to-Stand Test (1MSTST) is a simple, inexpensive, and practical assessment used to evaluate functional capacity in a small space. During the test, participants are asked to repeatedly sit down and stand up from a fixed chair as quickly as possible for one minute, without using their arms for support.

  Day 1

• Unsupported Upper-Limb Exercise Test (UULEX)

  Patients will be instructed to lift five bars consecutively and rhythmically until the onset of fatigue. The bars will have incremental weights of 200 g, 500 g, 1 kg, and 2 kg, respectively. The duration of the activity will be recorded to assess the patients' endurance levels.

  Day 1

• 6 Minutes Pegboard and Ring Test (6PBRT)

  The 6-Minute Pegboard and Ring Test (6PBRT) is designed to assess upper extremity functional capacity using unsupported arm movements. The setup includes four horizontally aligned bars: two at shoulder height and two positioned 20 cm above. Participants, seated with back support, sequentially transfer rings between the bars for six minutes, and the total number of rings moved serves as the performance score.

  Day 1

• 6 Minutes Walking Tests (6MWT)

  Total distance walked (in meters) during the 6MWT will be recorded. Higher distance reflects improved functional capacity.

  Day 1

Secondary Outcomes (8)

• Spirometric measurements (Forced vital capacity - FVC)

  Day 1

• Spirometric measurements (First second forced expiratory volume - FEV1)

  Day 1

• Spirometric measurements (FEV1/FVC ratio)

  Day 1

• Carbon monoxide diffusion capacity

  Day 1

• Modified Medical Research Council Dyspnea Score

  Day 1

Eligibility Criteria

• Age: 18 Years - 85 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Chest Diseases Clinic of Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital

You may qualify if:

• Our study included subjects who were diagnosed with IPF according to the ATS/ERS/JRS/ALAT guidelines, were over 18 years of age, had not changed their treatment for the last 3 months, and had a stable clinical status for the last 3 months.

You may not qualify if:

• Subjects with orthopedic comorbidity affecting upper extremity use, neurologic comorbidity, severe postural impairment, uncontrolled cardiac or cardiometabolic comorbidity, newly diagnosed cancer, obstructive pulmonary disease, recent surgery and those who refused to volunteer were excluded.

Sponsors & Collaborators

• Marmara University: lead

Study Sites (2)

Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital

Istanbul, Turkey (Türkiye)

Location

Süreyyapaşa

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Idiopathic Pulmonary Fibrosis

Condition Hierarchy (Ancestors)

Pulmonary Fibrosis; Lung Diseases, Interstitial; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Anıl Gökçen, Phsiotheraphist

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Physiotherapist

Study Record Dates

• First Submitted: July 30, 2025
• First Posted: August 12, 2025
• Study Start: August 4, 2025
• Primary Completion: October 13, 2025
• Study Completion: December 26, 2025
• Last Updated: March 3, 2026

Record last verified: 2026-03

Data Sharing

• IPD Sharing: Will not share

Locations

TU (2)